IOL Life Sciences incorporated as a subsidiary of IOL Chemicals and Pharmaceuticals
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022
All the capex is being met through internal accruals only
Under this initiative, 700 meals will be provided every day to four hospitals in Mumbai
The plant is scheduled to come on stream in September 2024
New collaboration will help customers reach sustainability goals for high-performance Udel PSU polymers in demanding applications.
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
Subscribe To Our Newsletter & Stay Updated